Tetratherix Limited (ASX:TTX)

Australia flag Australia · Delayed Price · Currency is AUD
4.000
+0.070 (1.78%)
Jan 30, 2026, 2:06 PM AEST
20.48%
Market Cap199.51M
Revenue (ttm)1.05M +21.9%
Net Income-9.43M
EPS-0.36
Shares Out50.77M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume17,333
Average Volume11,062
Open4.100
Previous Close3.930
Day's Range3.920 - 4.100
52-Week Range2.880 - 5.600
Betan/a
RSI71.73
Earnings DateNov 27, 2025

About Tetratherix

Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical device in the areas of bone regeneration, tissue spacing, and tissue healing applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 15
Stock Exchange Australian Securities Exchange
Ticker Symbol TTX
Full Company Profile

Financial Performance

In fiscal year 2025, Tetratherix's revenue was 1.05 million, an increase of 21.88% compared to the previous year's 863,651. Losses were -9.43 million, 269.1% more than in 2024.

Financial Statements